Osteoglycin
Template:PBB Osteoglycin (also called mimecan), encoded by the OGN gene, is a human protein.[1]
This gene encodes a protein which induces ectopic bone formation in conjunction with transforming growth factor beta. This protein is a small proteoglycan which contains tandem leucine-rich repeats (LRR). The gene expresses three transcript variants.[1]
The level of expression of this gene has been correlated with enlarged hearts and more specifically left ventricular hypertrophy.[2][3]
References
- ^ a b "Entrez Gene: OGN osteoglycin".
- ^ "Big hearts 'have genetic problem'". Health. BBC News. 2008-06-06. Retrieved 2008-06-07.
- ^ Petretto E, Sarwar R, Grieve I, Lu H, Kumaran MK, Muckett PJ, Mangion J, Schroen B, Benson M, Punjabi PP, Prasad SK, Pennell DJ, Kiesewetter C, Tasheva ES, Corpuz LM, Webb MD, Conrad GW, Kurtz TW, Kren V, Fischer J, Hubner N, Pinto YM, Pravenec M, Aitman TJ, Cook SA (May 2008). "Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass". Nat. Genet. 40 (5): 546–52. doi:10.1038/ng.134. PMC 2742198. PMID 18443592.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
Further reading
 | This article on a gene on human chromosome 9 is a stub. You can help Wikipedia by expanding it. |